Label: NMNPQQ powder

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated December 23, 2020

If you are a consumer or patient please visit this version.

View All Sections
  • DOSAGE & ADMINISTRATION

    serving Two capsule per day after meal.
    Usual adult usage: Six capsules maximum in 24 hours ifneeded. Do not exceed the limitation.

  • information

    Keep tightly closed, Protect from light.
    Store at Refrigerator is recommended. Store at controlled room temperature between 20℃ to 25 ℃ celsius or 68°F to 77°F Fahrenheit

  • INDICATIONS & USAGE

    This product is not recommended for cancer patients,pregnant women, and people age below 18 years oldbased on scientific research. lf you have any questions,please consult doctors or professionals for more information.

  • INACTIVE INGREDIENT

    Resveraltrol

  • ACTIVE INGREDIENT

    Nicotinamide mononucleotide 200mg 45%

    pyrroloquinoline quinone 50mg 10%

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of children's reach.

  • PURPOSE

    Every capsule contains
    200mg Nicotinamide Mononucleotide for NAD+ Support.
    50mg Pyrroloquinoline Quinone Enzymefor Mitochondrion Support

  • WARNINGS

    Sealed for safety and freshness free of artificial colors,preservatives , or sweeteners, No dairy, starch, wheat,gluten, yeast, soil, corn, egg tree nuts, or GMOs.

  • PRINCIPAL DISPLAY PANEL

    label

  • INGREDIENTS AND APPEARANCE
    NMNPQQ 
    nmnpqq powder
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11777-001
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PYRROLOQUINOLINEDIONE TRICARBOXYLIC ACID (UNII: 47819QGH5L) (PYRROLOQUINOLINEDIONE TRICARBOXYLIC ACID - UNII:47819QGH5L) PYRROLOQUINOLINEDIONE TRICARBOXYLIC ACID10 mg  in 100 mg
    NICOTINAMIDE RIBOTIDE (UNII: 2KG6QX4W0V) (NICOTINAMIDE RIBOTIDE - UNII:2KG6QX4W0V) NICOTINAMIDE RIBOTIDE45 mg  in 100 mg
    Inactive Ingredients
    Ingredient NameStrength
    RESVERATROL (UNII: Q369O8926L)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:11777-001-0160 in 1 PACKAGE12/23/2020
    11 mg in 1 CAPSULE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other12/23/2020
    Labeler - Golden Life Health Products Limited (117779683)
    Establishment
    NameAddressID/FEIBusiness Operations
    Golden Life Health Products Limited117779683manufacture(11777-001)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!